Phibro Animal Health Corporation Executive and Leadership Team

Daniel (Dani) Bendheim, the Chief Executive Officer & President at Phibro Animal Health Corporation, directs the overarching strategic vision for the global manufacturing and marketing of animal health pharmaceuticals. Overseeing the entire corporate portfolio, the Chief Executive Officer & President ensures alignment between research initiatives and market demands for animal nutrition products. This leadership role involves constant engagement with the Board to drive long-term value creation and operational excellence. By prioritizing innovation in performance products, Daniel (Dani) Bendheim shapes the competitive trajectory of the organization within the complex pharmaceutical landscape. Bendheim maintains a focus on sustainable growth, ensuring that the company meets the evolving needs of livestock producers worldwide. Through rigorous oversight of corporate governance and resource allocation, the Chief Executive Officer & President secures the stability and future expansion of the enterprise across diverse global markets.

Glenn David, the Chief Financial Officer at Phibro Animal Health Corporation, manages the fiscal health and capital allocation strategies for the global pharmaceutical manufacturer. Overseeing financial reporting, treasury functions, and investor relations, the Chief Financial Officer ensures the integrity of all economic data. This leadership role involves analyzing market trends to optimize the balance sheet and support the development of animal nutrition products. By implementing robust financial controls, Glenn David drives efficiency across the organization and mitigates risks associated with international trade. David collaborates with the executive team to fund research and development projects that enhance the company's performance products. Through disciplined fiscal management, the Chief Financial Officer provides the necessary capital structure to sustain operations and fuel expansion, ultimately strengthening the market position of the firm within the competitive animal health sector.

Larry Miller, the Chief Operating Officer at Phibro Animal Health Corporation, directs the daily operational activities and manufacturing processes for the global animal health pharmaceutical business. Overseeing production facilities and quality assurance protocols, the Chief Operating Officer ensures that all animal nutrition and performance products meet rigorous safety standards. This leadership role involves streamlining internal workflows to maximize output and reduce waste across the manufacturing network. By optimizing the production lifecycle, Larry Miller directly impacts the availability and reliability of essential health solutions for livestock producers. Miller coordinates with regional leaders to ensure that operational capacity aligns with global demand fluctuations. Through the implementation of advanced manufacturing technologies, the Chief Operating Officer drives continuous improvement and operational excellence, maintaining the company's reputation for quality and consistency in the highly regulated pharmaceutical industry.

Todd Armstrong, the Region President (North America) at Phibro Animal Health Corporation, directs all commercial activities and market expansion efforts within the North American territory. Overseeing the distribution of animal health pharmaceuticals and nutrition products, the Region President (North America) ensures that local livestock producers receive high-quality solutions tailored to regional agricultural needs. This leadership role involves managing sales teams and building relationships with key industry stakeholders to capture market share. By analyzing regional market dynamics, Todd Armstrong drives the implementation of growth strategies that align with the company's global objectives. Armstrong coordinates with manufacturing and supply chain leaders to ensure product availability across the continent. Through the execution of targeted marketing and sales initiatives, the Region President (North America) strengthens the brand presence and supports the overall financial performance of the organization in this critical market.

Michael Giambalvo, the Group President, Phibrochem & Ethanol Performance at Phibro Animal Health Corporation, directs the specialized chemical and ethanol performance product divisions. Overseeing the development and commercialization of these industrial solutions, the Group President, Phibrochem & Ethanol Performance ensures that the company maintains a strong foothold in the performance products market. This leadership role involves managing the unique supply chain and technical requirements associated with chemical manufacturing. By driving innovation in ethanol performance additives, Michael Giambalvo enhances the value proposition for industrial clients. Giambalvo collaborates with research teams to refine product formulations and expand the application of these technologies. Through the strategic management of these specialized business units, the Group President, Phibrochem & Ethanol Performance contributes to the diversification of the corporate portfolio and supports the long-term growth objectives of the firm.

Ramon Fuenmayor, the President, Region (South America) at Phibro Animal Health Corporation, directs all commercial operations and strategic initiatives across the South American market. Overseeing the sales and distribution of animal health pharmaceuticals, the President, Region (South America) ensures that the company addresses the specific health challenges faced by livestock producers in this region. This leadership role involves navigating complex regulatory environments and building strong partnerships with local agricultural enterprises. By identifying emerging market opportunities, Ramon Fuenmayor drives the adoption of advanced nutrition and performance products. Fuenmayor coordinates with global leadership to ensure that regional strategies remain consistent with the overall corporate mission. Through the effective management of local teams and resources, the President, Region (South America) secures a dominant market position and fosters sustainable growth for the organization within the South American agricultural sector.

Luis Velez, the Global President, Technical Operations & Supply Chain at Phibro Animal Health Corporation, directs the end-to-end supply chain and technical manufacturing processes on a global scale. Overseeing logistics, procurement, and production efficiency, the Global President, Technical Operations & Supply Chain ensures that animal health pharmaceuticals and nutrition products reach customers reliably. This leadership role involves optimizing the global network to reduce lead times and manage inventory costs effectively. By implementing advanced supply chain technologies, Luis Velez drives operational resilience and agility. Velez collaborates with regional presidents to align production capacity with shifting market demands. Through the rigorous management of technical operations, the Global President, Technical Operations & Supply Chain supports the company's ability to scale production and maintain high quality standards, ultimately ensuring the consistent delivery of essential products to livestock producers worldwide.

Samson Li, the Region President (Asia Pacific) at Phibro Animal Health Corporation, directs all commercial activities and market development efforts throughout the Asia Pacific region. Overseeing the sales and marketing of animal health pharmaceuticals, the Region President (Asia Pacific) ensures that the company meets the growing demand for livestock health solutions in this diverse market. This leadership role involves adapting global strategies to fit local agricultural practices and regulatory requirements. By fostering relationships with key distributors and producers, Samson Li drives the expansion of the product portfolio across the region. Li coordinates with global supply chain teams to ensure product availability and timely delivery. Through the execution of localized growth strategies, the Region President (Asia Pacific) strengthens the company's competitive position and contributes significantly to the overall success of the organization in the rapidly evolving Asia Pacific agricultural landscape.

Christopher Lee, the Chief of Staff, Office of the CDIO at Phibro Animal Health Corporation, coordinates digital transformation initiatives and information technology strategies across the global enterprise. Overseeing the integration of data-driven systems, the Chief of Staff, Office of the CDIO ensures that technological infrastructure supports the manufacturing and marketing of animal health pharmaceuticals. This leadership role involves facilitating communication between the Chief Digital Information Officer and various business units to accelerate innovation. By managing complex projects, Christopher Lee drives the adoption of digital tools that enhance operational efficiency and product development. Lee aligns technical resources with the broader corporate mission to improve livestock health outcomes. Through the synchronization of digital strategy and business objectives, the Chief of Staff, Office of the CDIO enables the organization to leverage data analytics for better decision-making and sustained competitive advantage.